MEPs voted to adopt their negotiating position on the controversial reform, but it will not be finalised until after the European elections in June. Despite concessions, the pharma industry is not happy
The new law is intended to allow EU citizens to access their health records when in any member state, and to choose whether or not to allow anonymized data to be shared for secondary use in research and public health
After long negotiations MEPs agreed on the EU’s pharmaceutical reform. It includes longer exclusivity for data filed to get marketing approval for new drugs. But pharma still isn’t happy
The creation of the European Health Data Space is in the balance, with talks between the Parliament and Council set to continue on Thursday, in a bid to agree a deal before the EU elections
Clinical research backed by the EU is bringing life-saving medicines and health tools to sub-Saharan Africa. This success story offers a valuable lesson as negotiations get underway on the next research programme
The Innovative Health Initiative is looking to fund interdisciplinary projects tackling shortcomings in heart disease management, data (under)use, biomarkers, healthcare workforce and long-term management of illnesses
Europe is home to some of the world’s most innovative food companies creating alternative proteins, but many are choosing to launch their products first in the US or Singapore
A COVID-19 testing laboratory that is surplus to requirements has been put up for sale by the UK government. Like other redundant research facilities before it, there is now an opportunity to build the local life sciences ecosystem
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.